Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is a paper indexed in PICO Portal from OpenAlex.

How many citations does Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo have?

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has 161 citations in the OpenAlex counts PICO Portal stores.

When was Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo published?

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has 2014 year in the PICO Portal index.

What is the open-access status of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?

Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has gold oa status in the PICO Portal index.

What is the DOI of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?

The DOI for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.

What is the PMID of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?

The PMID for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.

What is the OpenAlex record for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?

The OpenAlex for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.